p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, June 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 51 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 1 X users, with an upper bound of 792 followers.

p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma https://t.co/592U0on8d0

Reply Repost Favourite

p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma https://t.co/592U0on8d0

Reply Repost Favourite

p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma https://t.co/592U0on8d0

Reply Repost Favourite

p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma https://t.co/592U0on8d0

Reply Repost Favourite

p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma https://t.co/592U0on8d0

Reply Repost Favourite